Recommandation pour la prise en charge d'une RTU
Traitement de la maladie de Takayasu répondant aux critères d’Ishikawa et résistant aux traitements conventionnels (corticoïdes et immunosuppresseurs
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
n31eVHxABedeDdRf
Listen
